Background <p>In the United States and other resource-rich settings, video laryngoscopy is often favored for emergency intubation over direct laryngoscopy due to ease of use and improved performance in difficult airways. Video laryngoscopes pose a significant cost barrier against adoption in low- and middle-income countries (LMICs). In this study, we designed and tested a low-cost, 3D printable, periscope-based laryngoscope that achieves an indirect view of the vocal cords without the use of a video camera. The absence of expensive video components allows this device to be manufactured for $4.41 USD, making it well-suited for resource-limited settings.</p> Methods <p>The periscope-based laryngoscope was manufactured from polylactic acid (PLA) filament using a 3D printer. Manikin testing of the laryngoscope was performed by providers ranging from medical students to experienced physicians using the high fidelity Laerdal SimMan<sup>®</sup>. The novel laryngoscope was compared to commonly available direct and video laryngoscopes, and intubation times and first-pass success rates were recorded.</p> Results <p>A total of 121 trials were performed. In experienced intubators, faster intubation times were seen in the direct and periscope-based laryngoscopes compared to video laryngoscopes. Mean intubation times for experienced intubators were as follows: Direct Laryngoscope = 17.45&#xa0;s, Video Laryngoscope = 23.34&#xa0;s, and Novel Periscope-based Laryngoscope = 11.31&#xa0;s, with statistical significance (<i>p</i> &lt; 0.001) found between the Video and Periscope-based laryngoscope times. 100% of trials resulted in successful intubation of the trachea.</p> Conclusion <p>The periscope-based laryngoscope yielded intubation times and first-pass success rates that compare favorably to direct and video laryngoscopes, and it can be readily manufactured in multiple environments at a low price point without proprietary industrial technology. Next steps include human clinical trials and regulatory approvals prior to clinical adoption of the novel device.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A periscope-based, 3D printed indirect laryngoscope for resource limited settings: a non-randomized observational manikin trial

  • Phillip R. Schmitt,
  • Samantha Maguire,
  • Eliza Sternlicht,
  • Austin M. Quinn,
  • Whit Fisher,
  • Andrew Beck

摘要

Background

In the United States and other resource-rich settings, video laryngoscopy is often favored for emergency intubation over direct laryngoscopy due to ease of use and improved performance in difficult airways. Video laryngoscopes pose a significant cost barrier against adoption in low- and middle-income countries (LMICs). In this study, we designed and tested a low-cost, 3D printable, periscope-based laryngoscope that achieves an indirect view of the vocal cords without the use of a video camera. The absence of expensive video components allows this device to be manufactured for $4.41 USD, making it well-suited for resource-limited settings.

Methods

The periscope-based laryngoscope was manufactured from polylactic acid (PLA) filament using a 3D printer. Manikin testing of the laryngoscope was performed by providers ranging from medical students to experienced physicians using the high fidelity Laerdal SimMan®. The novel laryngoscope was compared to commonly available direct and video laryngoscopes, and intubation times and first-pass success rates were recorded.

Results

A total of 121 trials were performed. In experienced intubators, faster intubation times were seen in the direct and periscope-based laryngoscopes compared to video laryngoscopes. Mean intubation times for experienced intubators were as follows: Direct Laryngoscope = 17.45 s, Video Laryngoscope = 23.34 s, and Novel Periscope-based Laryngoscope = 11.31 s, with statistical significance (p < 0.001) found between the Video and Periscope-based laryngoscope times. 100% of trials resulted in successful intubation of the trachea.

Conclusion

The periscope-based laryngoscope yielded intubation times and first-pass success rates that compare favorably to direct and video laryngoscopes, and it can be readily manufactured in multiple environments at a low price point without proprietary industrial technology. Next steps include human clinical trials and regulatory approvals prior to clinical adoption of the novel device.